# Mutational Profiling

## Data Description

* 0 represents no mutation, 1 represents a mutation
* Survive relates to the survival outcome of the patient. SurviveTime is in days (7300 chosen for alive patients).

* Ovarian Cancer Patients
  * 435 count
  * TP53, BRCA1, BRCA2, KMT2C, CDK12, CSMD3, TTN, MUC16, NF1, PALB2, RB1, PTEN, FOXM1, BRIP1, KRAS, RASA1, CHEK2, RAD50, RAD51C/D, MRE11A, NBN, FANCE, FANCD2, ATR, ATM, MSH2, PMS2, MLH1, MSH6, FAT1, FAT2, FAT3, FAT4
* Uterine Cancer Patients
  * 167 count
  * FANCE, ATR, FAT3, MSH6, CDK12, CSMD3, FAT1, PMS2, BRIP1, FAT4, BRCA2, MUC16, PALB2, KRAS, TP53, PTEN, BRCA1, MSH2, KMT2C, NF1, ATM, FANCD2, NBN, CHEK2, MLH1
